PT1546152E - Derivados de epotilona - Google Patents
Derivados de epotilona Download PDFInfo
- Publication number
- PT1546152E PT1546152E PT03747872T PT03747872T PT1546152E PT 1546152 E PT1546152 E PT 1546152E PT 03747872 T PT03747872 T PT 03747872T PT 03747872 T PT03747872 T PT 03747872T PT 1546152 E PT1546152 E PT 1546152E
- Authority
- PT
- Portugal
- Prior art keywords
- epothilone
- analogs
- epothilone derivatives
- epoxide
- potent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Silicon Polymers (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40053502P | 2002-08-02 | 2002-08-02 | |
US48093303P | 2003-06-24 | 2003-06-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1546152E true PT1546152E (pt) | 2008-03-12 |
Family
ID=31720540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03747872T PT1546152E (pt) | 2002-08-02 | 2003-08-01 | Derivados de epotilona |
Country Status (12)
Country | Link |
---|---|
US (2) | US7169930B2 (pt) |
EP (1) | EP1546152B1 (pt) |
JP (1) | JP4276171B2 (pt) |
CN (1) | CN100439374C (pt) |
AT (1) | ATE381569T1 (pt) |
AU (1) | AU2003266961A1 (pt) |
BR (1) | BR0313198A (pt) |
CA (1) | CA2494259A1 (pt) |
DE (1) | DE60318224T2 (pt) |
ES (1) | ES2297189T3 (pt) |
PT (1) | PT1546152E (pt) |
WO (1) | WO2004014919A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU756699B2 (en) * | 1996-12-03 | 2003-01-23 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6660758B1 (en) * | 1996-12-13 | 2003-12-09 | The Scripps Research Institute | Epothilone analogs |
US20020058286A1 (en) * | 1999-02-24 | 2002-05-16 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto and analogues thereof |
JP4791183B2 (ja) | 2002-08-23 | 2011-10-12 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | エポチロン、その中間体、類似体の合成およびその使用 |
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
WO2005020989A1 (en) * | 2003-09-02 | 2005-03-10 | Novartis Ag | Cancer treatment with epothilones |
GB0405898D0 (en) | 2004-03-16 | 2004-04-21 | Novartis Ag | Organic compounds |
US20060121511A1 (en) | 2004-11-30 | 2006-06-08 | Hyerim Lee | Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents |
CN101535492A (zh) | 2005-02-11 | 2009-09-16 | 南加州大学 | 表达含有二硫键的蛋白质的方法 |
CN101360494A (zh) * | 2005-11-22 | 2009-02-04 | 斯克里普斯研究学院 | 高效埃博霉素的化学合成 |
WO2007130501A2 (en) * | 2006-05-01 | 2007-11-15 | University Of Southern California | Combination therapy for treatment of cancer |
WO2010056901A2 (en) | 2008-11-13 | 2010-05-20 | University Of Southern California | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
AU2011255647A1 (en) | 2010-05-18 | 2012-11-15 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
US9717803B2 (en) | 2011-12-23 | 2017-08-01 | Innate Pharma | Enzymatic conjugation of polypeptides |
EP2872894B1 (en) | 2012-07-13 | 2019-04-17 | Innate Pharma | Screening of conjugated antibodies |
US10036010B2 (en) | 2012-11-09 | 2018-07-31 | Innate Pharma | Recognition tags for TGase-mediated conjugation |
WO2014140300A1 (en) | 2013-03-15 | 2014-09-18 | Innate Pharma | Solid phase tgase-mediated conjugation of antibodies |
US10071169B2 (en) | 2013-06-20 | 2018-09-11 | Innate Pharma | Enzymatic conjugation of polypeptides |
AU2014283185B2 (en) | 2013-06-21 | 2019-05-02 | Innate Pharma | Enzymatic conjugation of polypeptides |
WO2019092148A1 (en) | 2017-11-10 | 2019-05-16 | Innate Pharma | Antibodies with functionalized glutamine residues |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6380394B1 (en) * | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
US6441186B1 (en) * | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
US6380395B1 (en) * | 1998-04-21 | 2002-04-30 | Bristol-Myers Squibb Company | 12, 13-cyclopropane epothilone derivatives |
PT1420780E (pt) * | 2001-08-23 | 2008-12-29 | Novartis Ag | Análogos ciclopropilados e ciclobutilados da epotilona |
WO2003026744A1 (en) * | 2001-09-25 | 2003-04-03 | Alcon, Inc. | The use of epothilones and analogs in conjunction with ophthalmic surgery |
-
2003
- 2003-08-01 ES ES03747872T patent/ES2297189T3/es not_active Expired - Lifetime
- 2003-08-01 WO PCT/EP2003/008554 patent/WO2004014919A1/en active Search and Examination
- 2003-08-01 CA CA002494259A patent/CA2494259A1/en not_active Abandoned
- 2003-08-01 DE DE60318224T patent/DE60318224T2/de not_active Expired - Fee Related
- 2003-08-01 CN CNB038186446A patent/CN100439374C/zh not_active Expired - Fee Related
- 2003-08-01 PT PT03747872T patent/PT1546152E/pt unknown
- 2003-08-01 EP EP03747872A patent/EP1546152B1/en not_active Expired - Lifetime
- 2003-08-01 AT AT03747872T patent/ATE381569T1/de not_active IP Right Cessation
- 2003-08-01 BR BR0313198-0A patent/BR0313198A/pt not_active IP Right Cessation
- 2003-08-01 AU AU2003266961A patent/AU2003266961A1/en not_active Abandoned
- 2003-08-01 JP JP2004526852A patent/JP4276171B2/ja not_active Expired - Fee Related
- 2003-08-04 US US10/634,537 patent/US7169930B2/en not_active Expired - Fee Related
-
2006
- 2006-08-28 US US11/511,610 patent/US20060293527A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2297189T3 (es) | 2008-05-01 |
CN100439374C (zh) | 2008-12-03 |
CA2494259A1 (en) | 2004-02-19 |
DE60318224D1 (de) | 2008-01-31 |
US20040072870A1 (en) | 2004-04-15 |
US7169930B2 (en) | 2007-01-30 |
WO2004014919A1 (en) | 2004-02-19 |
EP1546152A1 (en) | 2005-06-29 |
AU2003266961A1 (en) | 2004-02-25 |
BR0313198A (pt) | 2005-07-12 |
CN1675220A (zh) | 2005-09-28 |
ATE381569T1 (de) | 2008-01-15 |
EP1546152B1 (en) | 2007-12-19 |
JP2006503814A (ja) | 2006-02-02 |
US20060293527A1 (en) | 2006-12-28 |
DE60318224T2 (de) | 2009-01-29 |
JP4276171B2 (ja) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1546152E (pt) | Derivados de epotilona | |
NZ607880A (en) | Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production | |
UA88626C2 (en) | Neck brace | |
UY27878A1 (es) | Derivados de indolinfenilsulfonamida | |
ECSP055626A (es) | Nuevos conjugados de efectores, procedimientos para su preparación y su uso farmacéutico | |
PL374588A1 (en) | Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides | |
IL162461A0 (en) | Polymorphs of clopidogrel hydrogensulfate | |
UY28294A1 (es) | Dihidroquinazolinas sustituidas | |
EP1621226A4 (en) | REMOVABLE SOFT STENT WITH EXCELLENT ABILITY TO FOLLOW A BLOOD VESSEL | |
HK1089671A1 (en) | Novel imidazole derivatives, the production thereof, and the use of the same as a medicament | |
ECSP056057A (es) | Compuestos de benzo[1,2,5]tiadiazole | |
TW200637806A (en) | 2-alkylcycloalk(en)ylcarboxamides | |
UY29189A1 (es) | Nonadepsipeptidos acilados ii | |
EP1629861A4 (en) | SOFT STENT WITH EXCELLENT BLOOD VESSEL TRACKING | |
HN2006007774A (es) | Imidazoles sustituidos con heterociclilamida | |
DOP2006000024A (es) | Tiazolidinonas, su preparación y su uso como medicamento | |
UY28542A1 (es) | Amidas macrocíclicas antibacterianas | |
EP1387108A3 (de) | Radiallager | |
EA200500326A1 (ru) | Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента | |
UY27733A1 (es) | Derivados de ciclopenteno. | |
TW200732327A (en) | Novel compound | |
AU2003227593A1 (en) | New analogs of nitrobenzylthioinosine | |
AU2003285404A1 (en) | Method for cosmetic body treatment to enhance the silhouette and to develop the female bust, and double-acting cosmetic composition therefor | |
WO2005000843A3 (fr) | Benzothiazole-4,7-diones et benzoxazole-4,7-diones substituees en position 5 ou 6 et leurs procedes de preparation | |
ATE275551T1 (de) | Halogenpyrimidine |